Evidence map›Paper›PMID 35003019›Full record

ArticleFrontiers in microbiology2021

Prevalence, Risk Factors, and Genetic Characterization of Extended-Spectrum Beta-Lactamase

Milen Milenkov, Saida Rasoanandrasana, Lalaina Vonintsoa Rahajamanana, Rivo Solo Rakotomalala, Catherine Ainamalala Razafindrakoto, Christian Rafalimanana, Emile Ravelomandranto, Zakasoa Ravaoarisaina, Emilie Westeel, Marie Petitjean and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Lessons from a global antimicrobial resistance surveillance network.Bulletin of the World Health Organization · 2023
    Article
  15. Article
  16. Article
  17. Prevalence and characterization of ESBL-producingFrontiers in public health · 2023
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Milen MilenkovFondation Mérieux, Lyon, France.
Saida RasoanandrasanaLaboratoire de Bactériologie, CHU Joseph Raseta Befelatanana, RESAMAD Network, Antananarivo, Madagascar.
Lalaina Vonintsoa RahajamananaLaboratoire de Bactériologie, CHU Mère-Enfant Tsaralalana, RESAMAD Network, Antananarivo, Madagascar.
Rivo Solo RakotomalalaLaboratoire de Bactériologie, CHU PZaGa Androva, RESAMAD Network, Mahajanga, Madagascar.
Catherine Ainamalala RazafindrakotoLaboratoire de Bactériologie, CHU Morafeno, RESAMAD Network, Toamasina, Madagascar.
Christian RafalimananaLaboratoire de Bactériologie, CHU Joseph Ravoahangy Andrianavalona, RESAMAD Network, Antananarivo, Madagascar.
Emile RavelomandrantoLaboratoire de Bactériologie, CHRR Alaotra Mangoro, RESAMAD Network, Ambatondrazaka, Madagascar.
Zakasoa RavaoarisainaCHU Mère Enfant Ambohimiandra, RESAMAD Network, Antananarivo, Madagascar.
Emilie WesteelFondation Mérieux, Lyon, France.
Marie PetitjeanUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Jimmy MullaertUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Olivier ClermontUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Laurent RaskineFondation Mérieux, Lyon, France.
Luc Hervé SamisonCentre d'Infectiologie Charles Mérieux, University of Antananarivo, Antananarivo, Madagascar.
Hubert EndtzFondation Mérieux, Lyon, France.
Antoine AndremontUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Erick DenamurUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Florence Komurian-PradelFondation Mérieux, Lyon, France.
Laurence Armand-LefevreUniversité de Paris, IAME, INSERM UMR 1137, Paris, France.
Fondation Mérieux · FRInserm · FRAssociation Vahatra · MGAssistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Appliquée au Developpement Rural · MGErasmus MC · NLUniversité de Mahajanga · MGUniversité Paris Cité · FRUniversity of Antananarivo · MGUniversity of Toamasina · MG

Funding

Wellcome Trust
6 · The paper itself

Abstract

Antimicrobial resistance is a major public health concern worldwide affecting humans, animals and the environment. However, data is lacking especially in developing countries. Thus, the World Health Organization developed a One-Health surveillance project called Tricycle focusing on the prevalence of ESBL-producing

Indexed as

digestive carriageE. coliepidemiologyextended-spectrum beta-lactamase (ESBL)Madagascarwhole genome sequencing

Identifiers

PMID35003019
PMCPMC8740230
OpenAlexW4200281472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.